Search

Jeffrey R Luber

from Natick, MA
Age ~57

Jeffrey Luber Phones & Addresses

  • 7 Allison Way, Natick, MA 01760 (508) 650-3673
  • Shrewsbury, MA
  • Providence, RI
  • 1 White Birch Ln, Grafton, MA 01519
  • Westborough, MA
  • Upton, MA
  • Hamden, CT
  • 5121 Avalon Way, Shrewsbury, MA 01545

Work

Company: SynapDx Corp. Address: 4 Hartwell Pl, Lexington, MA 02421

Education

Degree: Graduate or professional degree

Ranks

Licence: Massachusetts - Active Date: 1996

Professional Records

Lawyers & Attorneys

Jeffrey Luber Photo 1

Jeffrey R. Luber, Lexington MA - Lawyer

View page
Address:
SynapDx Corp.
4 Hartwell Pl, Lexington, MA 02421
(508) 485-5820 (Office)
Licenses:
Massachusetts - Active 1996
Jeffrey Luber Photo 2

Jeffrey Luber - Lawyer

View page
ISLN:
913545254
Admitted:
1996
Jeffrey Luber Photo 3

Jeffrey Luber, Marlborough MA - Lawyer

View page
Address:
100 Campus Dr, Marlborough, MA 01752
Phone:
(508) 683-1211 (Phone)
Experience:
28 years
Jurisdiction:
Massachusetts (1996)
Memberships:
Massachusetts State Bar (1996)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jeffrey Luber
Chief Financial Officer, Vice-President
Synapdx Corp
Medical Laboratory
153 Cordaville Rd, Southborough, MA 01772
25K Olympia Ave, Woburn, MA 01801
(508) 485-5820
Jeffrey Luber
CEO
Exact Sciences
Noncommercial Research Organization · Research & Development in Biotechnology
100 Campus Dr, Marlboro, MA 01752
(508) 683-1200, (508) 683-1201

Publications

Us Patents

Methods And Systems For Determining Autism Spectrum Disorder Risk

View page
US Patent:
20180348199, Dec 6, 2018
Filed:
Aug 6, 2018
Appl. No.:
16/055966
Inventors:
- Burlington NC, US
Doris Damian - Lexington MA, US
Maciej Pacula - Lexington MA, US
Mark A. DePristo - Lexington MA, US
Jeffrey R. Luber - Lexington MA, US
Assignee:
Laboratory Corporation of America Holdings - Burlington NC
International Classification:
G01N 33/49
G16H 50/20
G16H 50/30
G06F 19/00
G01N 33/68
Abstract:
In certain embodiments, the invention stems from the discovery that analysis of population distribution curves of metabolite levels in blood can be used to facilitate predicting risk of autism spectrum disorder (ASD) and/or to differentiate between ASD and non-ASD developmental delay (DD) in a subject. In certain aspects, information from assessment of the presence, absence, and/or direction (upper or lower) of a tail effect in a metabolite distribution curve is utilized to predict risk of ASD and/or to differentiate between ASD and DD.

Sample Retrieval And Genetic Analysis Thereof

View page
US Patent:
20170073739, Mar 16, 2017
Filed:
Sep 15, 2016
Appl. No.:
15/266726
Inventors:
- Cambridge MA, US
Jeffrey Luber - Cambridge MA, US
International Classification:
C12Q 1/68
Abstract:
Retrieval of one or more samples from a pediatric subject for genetic analysis of the subject's nucleic acid is often invasive and inconvenient. Methods for analyzing nucleic acid include non-invasive and/or convenient methods of sample retrieval such as the retrieval of one or more samples for genetic analysis from a patient that may have an infection in conjunction with testing for the infection. In one aspect, the infection is strep throat. Methods for analyzing nucleic acid may also include the retrieval of a sample from a placenta that has been delivered during birth of a child. In one aspect, the sample is cord blood and in another aspect the sample is chorion tissue. Methods for analyzing nucleic acid include conducting a genetic analysis on the retrieved sample by exposing a nucleic acid to a plurality of MIPs and subsequently sequencing and aligning and assembling the reads generated therefrom.

Methods And Systems For Determining Autism Spectrum Disorder Risk

View page
US Patent:
20160091480, Mar 31, 2016
Filed:
Sep 25, 2015
Appl. No.:
14/866791
Inventors:
- Lexington MA, US
Doris Damian - Lexington MA, US
Maciej Pacula - Lexington MA, US
Mark A. DePristo - Lexington MA, US
Jeffrey R. Luber - Lexington MA, US
International Classification:
G01N 33/49
Abstract:
In certain embodiments, the invention stems from the discovery that analysis of population distribution curves of metabolite levels in blood can be used to facilitate predicting risk of autism spectrum disorder (ASD) and/or to differentiate between ASD and non-ASD developmental delay (DD) in a subject. In certain aspects, information from assessment of the presence, absence, and/or direction (upper or lower) of a tail effect in a metabolite distribution curve is utilized to predict risk of ASD and/or to differentiate between ASD and DD.

Methods And Systems For Determining Autism Spectrum Disorder Risk

View page
US Patent:
20150294081, Oct 15, 2015
Filed:
Sep 22, 2014
Appl. No.:
14/493141
Inventors:
- Lexington MA, US
Doris Damian - Lexington MA, US
Maciej Pacula - Lexington MA, US
Mark A. DePristo - Lexington MA, US
Jeffrey R. Luber - Lexington MA, US
Stanley N. Lapidus - Lexington MA, US
International Classification:
G06F 19/00
G01N 33/49
Abstract:
In certain embodiments, the invention stems from the discovery that analysis of population distribution curves of metabolite levels in blood can be used to facilitate predicting risk of autism spectrum disorder (ASD) and/or to differentiate between ASD and non-ASD developmental delay (DD) in a subject. In certain aspects, information from assessment of the presence, absence, and/or direction (upper or lower) of a tail effect in a metabolite distribution curve is utilized to predict risk of ASD and/or to differentiate between ASD and DD.
Jeffrey R Luber from Natick, MA, age ~57 Get Report